These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 7902062

  • 1. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M, Hao XY, Larsson R, Nygren P, Tsuruo T, Mannervik B, Bergh J.
    Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
    [Abstract] [Full Text] [Related]

  • 2. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
    Ganapathi R, Kuo T, Teeter L, Grabowski D, Ford J.
    Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
    [Abstract] [Full Text] [Related]

  • 3. Suramin inhibits the growth of human breast cancer cell lines. Studies on parental lines and corresponding sublines with acquired doxorubicin resistance with and without expression of P-glycoprotein.
    Lindman H, Taube A, Bergh JC.
    Anticancer Res; 1994 Jan; 14(2A):363-6. PubMed ID: 7912491
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
    Slovak ML, Hoeltge GA, Dalton WS, Trent JM.
    Cancer Res; 1988 May 15; 48(10):2793-7. PubMed ID: 2896069
    [Abstract] [Full Text] [Related]

  • 5. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH, Lewis AD, Ehsan MN, Sikic BI.
    Cancer Res; 1991 Oct 01; 51(19):5181-7. PubMed ID: 1717140
    [Abstract] [Full Text] [Related]

  • 6. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B, McCauley MD, Safa AR.
    Biochemistry; 1998 Aug 18; 37(33):11679-91. PubMed ID: 9709006
    [Abstract] [Full Text] [Related]

  • 7. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
    Matsumoto Y, Takano H, Nagao S, Fojo T.
    Jpn J Cancer Res; 2001 Sep 18; 92(9):968-74. PubMed ID: 11572765
    [Abstract] [Full Text] [Related]

  • 8. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
    Armstrong DK, Gordon GB, Hilton J, Streeper RT, Colvin OM, Davidson NE.
    Cancer Res; 1992 Mar 15; 52(6):1416-21. PubMed ID: 1540950
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
    Wang J, Zhang J, Zhang L, Zhao L, Fan S, Yang Z, Gao F, Kong Y, Xiao GG, Wang Q.
    Oncol Rep; 2011 Nov 15; 26(5):1081-9. PubMed ID: 21805041
    [Abstract] [Full Text] [Related]

  • 13. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
    Moscow JA, Townsend AJ, Cowan KH.
    Mol Pharmacol; 1989 Jul 15; 36(1):22-8. PubMed ID: 2747627
    [Abstract] [Full Text] [Related]

  • 14. Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin.
    Larsson R, Bergh J, Nygren P.
    Anticancer Res; 1991 Jul 15; 11(1):455-9. PubMed ID: 1850223
    [Abstract] [Full Text] [Related]

  • 15. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
    Politi PM, Arnold ST, Felsted RL, Sinha BK.
    Mol Pharmacol; 1990 Jun 15; 37(6):790-6. PubMed ID: 1972771
    [Abstract] [Full Text] [Related]

  • 16. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH.
    Cancer Res; 1994 Jan 01; 54(1):152-8. PubMed ID: 7903202
    [Abstract] [Full Text] [Related]

  • 17. Phenotypic instability of drug sensitivity in a human colon carcinoma cell line.
    Ferguson PJ, Cheng YC.
    Cancer Res; 1989 Mar 01; 49(5):1148-53. PubMed ID: 2563672
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.